Veradermics, Incorporated (NYSE: MANE)
Salud · Farmacéuticas · US
129,66 $
-4,16 % hoy · +243,5 % 1 año
Veradermics, Incorporated (NYSE: MANE) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 5,47 mil M $ y tiene 37 empleados.
En los últimos doce meses la acción ha subido un 243,5 % y ha cotizado entre 32,00 y 156,56.
Tweenvest puntúa a Veradermics, Incorporated en cuatro factores: calidad 45/100, valor 100/100. Su punto más fuerte es valor.
Evolución de la cotización de MANE
Cifras clave
- Capitalización
- 5,47 mil M $
- Ingresos (últ. 12 m)
- —
- PER
- -58,46
- BPA
- -40,02
- Rent. por dividendo
- —
- Beta (5 años)
- —
- Máximo 52 semanas
- 156,56 $
- Mínimo 52 semanas
- 32,00 $
- Volumen medio (3 m)
- —
- Acciones en circulación
- 42,20 M
- Empleados
- 37
- Próximos resultados
- —
Sobre Veradermics, Incorporated
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL. Furthermore, Veradermics is progressing with VDMN, an innovative dissolvable microarray patch technology employing immunotherapy for common warts. Its research also extends to VDAA for addressing alopecia areata, and VDMC, aimed at molluscum contagiosum. Collectively, the firm's product candidates target conditions such as androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. Veradermics caters to healthcare practitioners and clinicians specializing in dermatologic and aesthetic care for patients of all ages, in addition to the wider medical and scientific community engaged in dermatology. Founded in 2019, the company is based in New Haven, Connecticut.
- ISIN
- US9229671048
- Fundada en
- 2019
- Cotiza desde
- 4 feb 2026
- Bolsa
- New York Stock Exchange
- Divisa
- USD
Otras empresas de farmacéuticas
| Empresa | Capitalización | Precio | Día |
|---|---|---|---|
| Supernus, Inc.NasdaqGS: SUPN | 6,17 mil M $ | 29,72 $ | +1,78 % |
| Abbott India LimitedBSE: 500488 | 5,97 mil M $ | 26.413,50 Rs | -0,71 % |
| Gland Pharma LimitedNSEI: GLAND | 5,85 mil M $ | 3334,10 Rs | +0,77 % |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | 5,66 mil M $ | 2018,00 ¥ | -0,49 % |
| Shanghai Allist Pharmaceuticals Co., Ltd.SHSE: 688578 | 5,33 mil M $ | 78,99 CN¥ | -1,24 % |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | 5,15 mil M $ | 87.900,00 ₩ | +0,34 % |
| Liquidia CorporationNasdaqCM: LQDA | 5,08 mil M $ | 56,40 $ | -0,58 % |
| Ipca Laboratories LimitedNSEI: IPCALAB | 5,07 mil M $ | 1884,00 Rs | -0,83 % |